Nusinersen
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Nusinersen, covering 2017-03-13 to 2026-08-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD) [Phase 3]